Atovaquone (Form A)
Atovaquone is an antimicrobial indicated for the prevention and treatment of Pneumocystis jirovecii pneumonia (PCP) and for the prevention and treatment of Plasmodium falciparum malaria.
Systematic Name
2-hydroxy-3-[(1r,4r)-4-(4-chlorophenyl)cyclohexyl]-1,4-dihydronaphthalene-1,4-dione
Brand Name(S)
Malarone, Mepron
Therapeutic Category
Anti-protozoal
Suitable Formulations
Solid
Approvals
US DMF
EU-WC